Mc Carthy Asset Management, Inc. Edwards Lifesciences Corp Transaction History

Mc Carthy Asset Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$101.96 - $128.34 $24,368 - $30,673	-239 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$106.37 - $130.68 $14,147 - $17,380	-133 Reduced 35.75%	239 $31,000
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $19,449 - $23,199	-189 Reduced 33.69%	372 $42,000
Q2 2021 Aug 05, 2021	BUY	$83.84 - $104.76 $47,034 - $58,770	561 New	561 $58,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Mc Carthy Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Mc Carthy Asset Management, Inc. with notifications on news.